Mebanazine (trade name Actomol) is a monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was previously used as an antidepressant in the 1960s, but has since been withdrawn due to hepatotoxicity.

[1][2][3] Mebanazine in animals is claimed to be a more potent MAOI than pheniprazine with a greater therapeutic index.

[4]

This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.